Bio-Rad Laboratories Inc. (BIO)
NYSE · Healthcare
Bio-Rad Laboratories Inc. Long Term Debt 2008–2025
Bio-Rad Laboratories Inc. annual long term debt history from 2009 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Bio-Rad Laboratories Inc. long term debt as of December 31, 2025: 1.20B, a 0.22% increase year-over-year.
- Bio-Rad Laboratories Inc. long term debt for 2025 were 1.20B, a 0.22% increase from 2024.
- Bio-Rad Laboratories Inc. long term debt for 2024 were 1.20B, a 0.80% decrease from 2023.
- Bio-Rad Laboratories Inc. long term debt for 2023 were 1.21B, a 1.04% increase from 2022.
- Bio-Rad Laboratories Inc. long term debt for 2022 were 1.20B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bio-Rad Laboratories Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1,203 |
| 2024 | $1,200 |
| 2023 | $1,210 |
| 2022 | $1,198 |
| 2021 | $11 |
| 2020 | $12 |
| 2019 | $14 |
| 2018 | $439 |
| 2013 | $436 |
| 2012 | $733 |
| 2011 | $732 |
| 2010 | $964 |
| 2009 | $738 |
Bio-Rad Laboratories Inc. Long Term Debt — FAQ
Bio-Rad Laboratories Inc. (BIO) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIO's long term debt history?
The chart and table above show Bio-Rad Laboratories Inc.'s long term debt by year and by quarter, including the growth rate.